Robuta

https://scibase.com/uk/ceo-letter-2/ CEO-LETTER 2 - SciBase ceo letterscibase https://scibase.com/us/comments-on-covid-19/ Comments on Covid-19 - SciBase Sep 9, 2025 - The consequences of the Covid19 outbreak have started to affect SciBase from mid-March, and there is a high risk that these could lead to a significant... commentscovidscibase https://www.inderes.fi/en/releases/bulletin-from-the-extraordinary-general-meeting-in-scibase-holding-ab-publ-2 Bulletin from the extraordinary general meeting in SciBase Holding AB (publ) - Inderes Today, an extraordinary general meeting has been held in SciBase Holding AB (publ) ("SciBase" or the "Company"). The general meeting resolved in accordance... extraordinary general meetingfrom the https://scibase.com/uk/scibase-publishes-the-annual-report-for-2019/ SciBase publishes the Annual report for 2019 - SciBase Sep 9, 2025 - SciBase hereby announces that the Annual report for 2019 is available at the Company's website www.scibase.com. the annual reportscibasepublishes https://scibase.com/de/notice-to-extraordinary-general-meeting-in-scibase-holding-ab-publ/ Notice to extraordinary general meeting in Scibase Holding AB (publ) - SciBase Sep 9, 2025 - Shareholders of SciBase Holding AB (publ), reg. no. 556773-4768 (the "Company"), are hereby summoned to an extraordinary general meeting to be held on 13 May... extraordinary general meetingnoticescibaseholdingab https://medtechspectrum.com/news/10/24342/scibase-surpasses-300000-patients-tested-with-nevisense-skin-cancer-detection-system.html SciBase Surpasses 300,000 Patients Tested with Nevisense Skin Cancer Detection System SciBase Surpasses 300,000 Patients Tested with Nevisense Skin Cancer Detection System skin cancer detection